In NSCLC cell lines, silencing WNT2 by siRNA or antagonizing WNT2 by anti-WNT2 monoclonal antibody could reduce the cytoplasmic β-catenin level and TCF/LEF transcriptional activity, and induce cellular apoptosis. This evidence concerns the gene WNT2 and non-small cell lung carcinoma.